<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9082">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05705596</url>
  </required_header>
  <id_info>
    <org_study_id>706014-2</org_study_id>
    <nct_id>NCT05705596</nct_id>
  </id_info>
  <brief_title>Impact of Hesperetin in Combination With Sucrose on Energy Metabolism</brief_title>
  <official_title>Einfluss Des süßmodulierenden Polyphenols Hesperetin in Kombination Mit Saccharose Auf Die Blutglukose-Regulierung Und Energieaufnahme in Abhängigkeit Der Süßwahrnehmung</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this cross-over intervention study is to investigate the influence of the&#xD;
      sweet-modulating substance hesperetin in combination with sucrose in comparison to an equally&#xD;
      sweet-tasting sucrose-only solution on markers of energy metabolism.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is designed as a randomised cross-over intervention study with two arms. The aim is&#xD;
      to investigate the influence of a 10% sucrose solution, corresponding to the sugar content of&#xD;
      a conventional soft drink, compared to an equally sweet-tasting 7% sucrose solution in&#xD;
      combination with 50 mg/L of the polyphenol hesperetin, on time-dependent blood glucose&#xD;
      fluctuations and ad libitum energy intake in metabolically healthy male volunteers.&#xD;
&#xD;
      To investigate the underlying mechanisms, the individual appetite score, metabolic and&#xD;
      hormonal responses to the interventions and circulating extracellular vesicles and their&#xD;
      miRNA composition will be measured. In addition, the participants' individual thresholds for&#xD;
      sweet taste, preference and consumption for sweet-tasting foods such as sugar and sweeteners,&#xD;
      and their body composition will be recorded as potential influencing factors.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 31, 2023</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2023</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in blood glucose concentration</measure>
    <time_frame>15, 30, 60, 90, and 120 minutes after drinking the test solution</time_frame>
    <description>Change compared to baseline in blood glucose concentration [mg/dL] in plasma samples after drinking the test solution</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in appetite score</measure>
    <time_frame>Difference between before and 120 minutes after drinking of the test solution</time_frame>
    <description>Change compared to baseline in the subjective rating of the individual feeling of hunger, fullness, as well as appetite for a snack or for something sweet on a digital visual analog scale in comparison to baseline</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in food intake</measure>
    <time_frame>120 minutes after drinking of the test solution</time_frame>
    <description>Ad libitum food intake from a standardized breakfast</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in blood glucose regulating hormones</measure>
    <time_frame>15, 30, 60, 90, and 120 minutes after drinking the test solution</time_frame>
    <description>Change compared to baseline in Insulin, Glucagon-like peptide 1, and Gastric inhibitory polypeptide concentrations [mmol/L] in plasma samples after drinking the test solution</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in satiety hormones</measure>
    <time_frame>15, 30, 60, 90, and 120 minutes after drinking the test solution</time_frame>
    <description>Change compared to baseline in Polypeptide Y, grehlin, cholecystokinin, and serotonin concentrations [mmol/L] in plasma samples after drinking the test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in circulating miRNA</measure>
    <time_frame>15, 30, 60, 90, and 120 minutes after drinking the test solution</time_frame>
    <description>Change compared to baseline in circulating extracellular vesicles and their miRNA composition</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Blood Glucose Fluctuations</condition>
  <condition>Hunger</condition>
  <arm_group>
    <arm_group_label>Sucrose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10% (w/v) sucrose in water</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hesperetin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>7% (w/v) sucrose in water + 50 mg/L Hesperetin</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sucrose</intervention_name>
    <description>10% sucrose corresponding to a regular soft drink</description>
    <arm_group_label>Sucrose</arm_group_label>
    <other_name>table sugar</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hesperetin</intervention_name>
    <description>increases sweetness of 7% sucrose solution to match sweetness of 10% sucrose solution</description>
    <arm_group_label>Hesperetin</arm_group_label>
    <other_name>(2S)-3',5,7-Trihydroxy-4'-methoxyflavan-4-one</other_name>
    <other_name>CAS number 520-33-2</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  male&#xD;
&#xD;
          -  healthy&#xD;
&#xD;
          -  non-smoking&#xD;
&#xD;
          -  normal taste responses towards sweet taste&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  female&#xD;
&#xD;
          -  regular smokers&#xD;
&#xD;
          -  disturbed glucose and/or lipid metabolism&#xD;
&#xD;
          -  regular intake of medication&#xD;
&#xD;
          -  known allergies against one of the test compounds&#xD;
&#xD;
          -  ageusia&#xD;
&#xD;
          -  alcohol or drug addiction&#xD;
&#xD;
          -  intake of antibiotics within the past 2 months&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barbara Lieder, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Vienna</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Christian Doppler Laboratory for Taste Research</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>May 2023</verification_date>
  <study_first_submitted>January 17, 2023</study_first_submitted>
  <study_first_submitted_qc>January 26, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 31, 2023</study_first_posted>
  <last_update_submitted>May 8, 2023</last_update_submitted>
  <last_update_submitted_qc>May 8, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Vienna</investigator_affiliation>
    <investigator_full_name>Barbara Lieder</investigator_full_name>
    <investigator_title>Professor and Vice Chair Department of Physiological Chemistry</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

